While on the other hand, the ratio of adjuvant radiotherapy in triple-negative subtype was higher than that in HER-2 overexpressing and luminal subtypes, which may probably due to higher proportion of large tumor (>5 cm), positive lymph nodes and breast conserving therapy in the latter. This evidence concerns the gene ERBB2 and neoplasm.